Drug-Induced Ocular Toxicity
Drug-Induced Ocular Toxicity is a research topic within Ophthalmology. Science Explorer counts 8k research works in it since 1950. 11.6% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the ocular toxicity and retinal disorders associated with medications such as chloroquine, hydroxychloroquine, tamoxifen, and ethambutol. It covers topics such as retinopathy, maculopathy, optic neuropathy, and cardiomyopathy induced by these drugs. The papers also discuss screening guidelines, imaging techniques like multifocal electroretinography and optical coherence tomography (OCT), and the implications for rheumatology care.
- Retinopathy
- Chloroquine
- Hydroxychloroquine
- Ocular Toxicity
- Drug-induced
- Optic Neuropathy
- Maculopathy
- Screening Guidelines
- Multifocal Electroretinography
- OCT Imaging
- Research works
- 8k fractional, since 1950
- In the world top 10%
- 932 per year above
- Top-10% rate
- 11.6% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +36% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Drug-Induced Ocular Toxicity research?
By volume, the United States and India publish the most (287 and 126 works in 2022–2025).
By volume, 2022–2025
- 1 United States 287 works
- 2 India 126 works
- 3 China 110 works
- 4 United Kingdom 59 works
- 5 France 54 works
- 6 Spain 40 works
- 7 Türkiye 40 works
- 8 Japan 39 works
- 9 Italy 35 works
- 10 Germany 33 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Drug-Induced Ocular Toxicity research?
By volume in 2022–2025, University of Toronto publishes the most Drug-Induced Ocular Toxicity research, followed by Philipps University of Marburg and All India Institute of Medical Sciences.
By volume, 2022–2025
- 1 University of TorontoCanada 6 works
- 2 Philipps University of MarburgGermany 6 works
- 3 All India Institute of Medical SciencesIndia 6 works
- 4 Creative CommonsUnited States 6 works
- 5 Aravind Eye HospitalIndia 6 works
- 6 Hanyang University Seoul HospitalSouth Korea 5 works
- 7 L V Prasad Eye InstituteIndia 5 works
- 8 Harvard UniversityUnited States 4 works
- 9 University College LondonUnited Kingdom 4 works
- 10 Post Graduate Institute of Medical Education and ResearchIndia 4 works
Where is Drug-Induced Ocular Toxicity research done?
The largest centres of Drug-Induced Ocular Toxicity research in 2022–2025 are Beijing (China), Paris (France), London (United Kingdom) and Seoul (South Korea).
Largest cities, 2022–2025
Is Drug-Induced Ocular Toxicity research growing?
Output in 2018–2022 was 36% higher than in 2013–2017, peaking in 2020. The fastest-growing topics are Drug-Induced Ocular Toxicity.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.